Fund III
1 known investors
Rose Pharma is a pharmaceutical company developing ROSE-010, an on-demand GLP-1 therapy aimed at treating acute pain from irritable bowel syndrome (IBS) as well as obesity and appetite control. The company is advancing the therapy through multiple clinical trials.
BiotechHealthtech